Literature DB >> 16785612

Japanese IGT subjects with high insulin response are far more frequently associated with the metabolic syndrome than those with low insulin response.

Yutaka Mori1, Kyouko Hoshino, Kuninobu Yokota, Yohta Itoh, Naoko Tajima.   

Abstract

Impaired glucose tolerance (IGT) represents a prediabetic state positioned somewhere between normal glucose tolerance and diabetes, which is also assumed to make individuals in this state highly susceptible to atherosclerotic disease. IGT also accounts for a highly heterogeneous population, with the condition varying from individual to individual. In this study, we stratified subjects with IGT by their insulin response and compare the pathology of IGT when it is associated with high or low insulin response to gain insight into the diverse pathology of IGT. Of the male corporate employees who underwent 75 g OGTT at the corporation's healthcare center, 150 individuals diagnosed with IGT (isolated IGT, combined IGT and IFG) comprised our study subjects. The study subjects were stratified into four quartiles by percentile AUC for insulin, and those in the 25th or less percentile were defined as the low insulin response group (n = 37), vs those in the 76th or greater percentile defined as the high insulin response group (n = 38), and these groups were compared. There was no significant difference observed between the two groups in regard to post-OGTT glucose response and area under the glucose curve. However, the high insulin response group was associated with higher BMI, subcutanesous fat area, uric acid levels, HOMA-beta cell values, and delta insulin/delta glucose (30 min) than the low insulin response group. The number of risk factors for the metabolic syndrome detected (as defined by the ATPIII diagnostic criteria) per subject was 2.84 +/- 0.17 and 2.08 +/- 0.20, respectively, in the high insulin response group and in the low insulin response group, with the number significantly (p < 0.05) higher in the high insulin response group. Furthermore, the incidence of the metabolic syndrome as defined by the ATPIII diagnostic criteria was 63.2% (24/38) in the high insulin response group vs 32.4% (12/27) in the low insulin response group, with the incidence significantly (p < 0.01) higher in the high insulin response group. Likewise, the incidence of the metabolic syndrome as defined by the Japanese diagnostic criteria was found to be significantly (p < 0.05) higher in the high insulin response group at 50% (19/38) compared to 27.0% (10/37) in the low insulin response group. Our study findings suggest that IGT subjects with high insulin response and those with low insulin response vary greatly in regard to the number of atherosclerotic risk factors complicated and the frequency with which they are associated with the metabolic syndrome. It is also shown in middle-aged Japanese males that of the two forms of IGT, IGT with high insulin response is more closely linked to the pathogenesis of atherosclerotic cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785612     DOI: 10.1385/ENDO:29:2:351

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  16 in total

1.  Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance.

Authors:  Y Tanaka; Y Atsumi; K Matsuoka; T Onuma; R Kawamori
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  Impaired fasting glucose is not a risk factor for atherosclerosis.

Authors:  M Hanefeld; T Temelkova-Kurktschiev; F Schaper; E Henkel; G Siegert; C Koehler
Journal:  Diabet Med       Date:  1999-03       Impact factor: 4.359

4.  Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

Authors:  S M Haffner; L Mykkänen; A Festa; J P Burke; M P Stern
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

5.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

Authors:  K Maeda; K Okubo; I Shimomura; T Funahashi; Y Matsuzawa; K Matsubara
Journal:  Biochem Biophys Res Commun       Date:  1996-04-16       Impact factor: 3.575

6.  Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

Authors:  Y Mori; K Hoshino; K Yokota; T Yokose; N Tajima
Journal:  Exp Clin Endocrinol Diabetes       Date:  2005-06       Impact factor: 2.949

7.  Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

Authors:  M Tominaga; H Eguchi; H Manaka; K Igarashi; T Kato; A Sekikawa
Journal:  Diabetes Care       Date:  1999-06       Impact factor: 19.112

8.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.

Authors:  K Hotta; T Funahashi; N L Bodkin; H K Ortmeyer; Y Arita; B C Hansen; Y Matsuzawa
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

9.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors:  Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

10.  Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.

Authors:  Alexander Tenenbaum; Michael Motro; Enrique Z Fisman; Ehud Schwammenthal; Yehuda Adler; Ilan Goldenberg; Jonathan Leor; Valentina Boyko; Lori Mandelzweig; Solomon Behar
Journal:  Circulation       Date:  2004-05-03       Impact factor: 29.690

View more
  3 in total

1.  Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats.

Authors:  Christopher G Ellis; Daniel Goldman; Madelyn Hanson; Alan H Stephenson; Stephanie Milkovich; Amina Benlamri; Mary L Ellsworth; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-05       Impact factor: 4.733

2.  Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase.

Authors:  Madelyn S Hanson; Alan H Stephenson; Elizabeth A Bowles; Randy S Sprague
Journal:  Exp Biol Med (Maywood)       Date:  2010-02

3.  Assessment of metabolic status in young Japanese females using postprandial glucose and insulin levels.

Authors:  Masae Sakuma; Megumi Sasaki; Sayaka Katsuda; Kana Kobayashi; Chiaki Takaya; Minako Umeda; Hidekazu Arai
Journal:  J Clin Biochem Nutr       Date:  2014-04-12       Impact factor: 3.114

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.